Effects of Benzodiazepine Exposure on Real-World Clinical Outcomes in Individuals at Clinical High-Risk for Psychosis.
Nicholas R LivingstonAndrea De MicheliRobert A McCutcheonEmma ButlerMarwa HamdanAnthony A GracePhilip McGuireAlice EgertonPaolo Fusar-PoliGemma ModinosPublished in: medRxiv : the preprint server for health sciences (2023)
BDZ exposure in CHR-P individuals was not associated with a reduction in the risk of psychosis transition or other adverse clinical outcomes. Results in the whole-unmatched sample suggest BDZ prescription may be more likely in CHR-P individuals with higher symptom severity.
Keyphrases